The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is putting together a series of 3-hours virtual meetings (12h00-15h00 UTC-time) called GloPID-R COVID-19 Research Synergy Meetings to bring together funded researchers and other key stakeholders on combating COVID-19.
The purpose of these meetings is to provide a platform to promote and establish collaboration and synergies between researchers funded by GloPID-R members. This will maximize the use of available resources, generate connections between ongoing research projects, create opportunities to share information on progress, barriers and outstanding research gaps and facilitate the progress of a collective effort to end COVID-19. Participants will include GloPID-R members and the researchers funded by their COVID-19 rapid response calls, representatives from the WHO, and other major research and funding organisations alongside contributors from countries affected by second peaks, waves, or high incidence.
Each session will be led by two co-chairs from leading research organisations and key stakeholders from across the world, followed by a series of researchers to speak about their projects and progress and challenges (chosen from projects funded by GloPID-R funders, as well as regional representation and representatives from resource limited settings). The sessions will end with 45 min of discussion on areas of synergy and how to move forward, common challenges and what can GloPID-R funders do to coordinate/remove barriers.
GloPID-R is the only alliance of its kind to bring together research funding organizations on a global scale to facilitate an effective and rapid research of a significant outbreak of a new or re-emerging infectious disease with epidemic and pandemic potential.
The need for the rapid development of essential diagnostics, vaccines and therapeutics at the outset of an emerging infectious disease outbreak was highlighted when Ebola struck in West Africa in 2014 and has been confirmed in the battle against COVID-19. This pandemic has underlined the importance of planning and investing in research and innovation before a health crisis occurs.
The sessions, each taking place at 12h00-15h00 UTC-time (8pm-11pm Singapore time) are:
16 July: Ending COVID-19: Vaccines
Co-Chairs: Melanie Saville (CEPI) and Anita Zaidi (BMGF)
17 July: Ending COVID-19: Therapeutics
Co-Chairs: Glenda Grey (SA MRC) and Valdiléa G. Veloso (INI, Fiocruz)
20 July: Preparing for Second Wave: Focus on Stopping Transmission
Co-Chairs: Marion Koopmans (EMC) and David Fisman (University of Toronto)
21 July: Social Sciences Research in COVID-19
Co-Chairs: Ken Rochel de Camargo (University of Rio de Janeiro) and Kristy Crooks (Hunter New England Health, Australia)
23 July: Summaries and Discussion Panel